One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Subscription Information
doi : 10.1016/S0085-2538(26)00442-4
Volume 110, Issue 2, August 2026, Page A3
The AFRAN Prevention and Advocacy Group advocates for chronic kidney disease care: fulfilling the right to kidney health in Africa
doi : 10.1016/j.kint.2026.05.002
Volume 110, Issue 2, August 2026, Pages 274-277
Hybrid CARs: rewiring macrophage signaling for targeted therapy in acute and chronic kidney inflammation
doi : 10.1016/j.kint.2026.01.009
Volume 110, Issue 2, August 2026, Pages 281-283
Phenotype first: a data-driven approach to genetic penetrance
doi : 10.1016/j.kint.2026.01.010
Volume 110, Issue 2, August 2026, Pages 284-287
The thirsty kidney: genomic adaptation to heat and aridity
doi : 10.1016/j.kint.2026.02.022
Volume 110, Issue 2, August 2026, Pages 288-290
Mitochondria poor but capacity rich? The paradox of podocyte respiration
doi : 10.1016/j.kint.2026.05.008
Volume 110, Issue 2, August 2026, Pages 291-293
Renal sensory nerves in injury: more than just sensing
doi : 10.1016/j.kint.2026.05.007
Volume 110, Issue 2, August 2026, Pages 294-296
When calcium crosstalk turns ferroptotic: the SERCA2–VDAC1 axis in AKI
doi : 10.1016/j.kint.2026.05.005
Volume 110, Issue 2, August 2026, Pages 297-300
Renal biopsy in patients with diabetes: still going strong after all these years
doi : 10.1016/j.kint.2026.05.003
Volume 110, Issue 2, August 2026, Pages 301-303
The next step in liquid biopsies: urinary extracellular vesicle proteomics in kidney diseases and responses to treatment
doi : 10.1016/j.kint.2026.05.004
Volume 110, Issue 2, August 2026, Pages 304-305
Neonatal acute kidney injury: diagnosis, recognition, and prevention
doi : 10.1016/j.kint.2026.02.043
Volume 110, Issue 2, August 2026, Pages 306-317
Tubulointerstitial diseases: an updated framework for diverse and emerging entities
doi : 10.1016/j.kint.2026.02.042
Volume 110, Issue 2, August 2026, Pages 318-336
Anti–glomerular basement membrane disease: variant forms and underlying mechanisms
doi : 10.1016/j.kint.2026.03.029
Volume 110, Issue 2, August 2026, Pages 337-348
Mitochondrial respiratory capacity in kidney podocytes is high, age-dependent, and sexually dimorphic
doi : 10.1016/j.kint.2026.04.016
Volume 110, Issue 2, August 2026, Pages 349-363
Nociceptive sensory nerves induce an IL4R?hi anti-inflammatory macrophage subset that protects against kidney ischemia-reperfusion injury
doi : 10.1016/j.kint.2026.04.022
Volume 110, Issue 2, August 2026, Pages 364-378
SERCA2 deficiency in tubular epithelial cells drives ferroptosis in acute kidney injury regulating endoplasmic reticulum mitochondrial calcium homeostasis via voltage dependent anion channel 1 oligomerization
doi : 10.1016/j.kint.2026.04.017
Volume 110, Issue 2, August 2026, Pages 379-399
The calcimimetic etelcalcetide restores cardiac function in chronic hyperphosphatemia via calcium sensing receptor–cAMP activation
doi : 10.1016/j.kint.2026.03.018
Volume 110, Issue 2, August 2026, Pages 400-412
Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophy
doi : 10.1016/j.kint.2026.03.019
Volume 110, Issue 2, August 2026, Pages 413-425
Clinical and histologic predictors of non-diabetic kidney disease in patients with diabetes mellitus
doi : 10.1016/j.kint.2026.03.015
Volume 110, Issue 2, August 2026, Pages 426-437
Distinct proteomic signatures of urinary extracellular vesicles link to albuminuria and treatment responses in diabetic kidney disease
doi : 10.1016/j.kint.2026.04.018
Volume 110, Issue 2, August 2026, Pages 438-450
A post hoc analysis of BLISS-LN found Belimumab plus mycophenolate mofetil improves kidney outcomes versus placebo plus mycophenolate mofetil in active lupus nephritis
doi : 10.1016/j.kint.2026.03.030
Volume 110, Issue 2, August 2026, Pages 451-462
Therapeutic efficacy and antigenicity of a novel PEGylated IgA protease in preclinical models of IgA nephropathy
doi : 10.1016/j.kint.2026.04.020
Volume 110, Issue 2, August 2026, Pages 463-476
Optimizing risk-benefit in highly sensitized kidney recipient antigen delisting increasing donor access
doi : 10.1016/j.kint.2026.04.023
Volume 110, Issue 2, August 2026, Pages 477-482
Urinary chloride unlocks the mechanism of hyponatremic seizures
doi : 10.1016/j.kint.2026.03.021
Volume 110, Issue 2, August 2026, Pages 483-486
Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background
doi : 10.1016/j.kint.2026.03.022
Volume 110, Issue 2, August 2026, Pages 487-489
Disappearing glomeruli: loss of linear IgG in anti-GBM nephritis
doi : 10.1016/j.kint.2025.12.041
Volume 110, Issue 2, August 2026, Pages 490-491
Migrating peritoneal dialysis catheter into an inguinal hernia
doi : 10.1016/j.kint.2025.12.035
Volume 110, Issue 2, August 2026, Pages 492-493
Empagliflozin-associated Armanni-Ebstein lesions in IgA nephropathy
doi : 10.1016/j.kint.2025.12.032
Volume 110, Issue 2, August 2026, Pages 494-495
Hypertension from UPJ obstruction by crossing renal vessel
doi : 10.1016/j.kint.2025.12.036
Volume 110, Issue 2, August 2026, Pages 496-497
The Case | Podocyte vacuolization and myelin figures in a young male with proteinuria
doi : 10.1016/j.kint.2026.03.011
Volume 110, Issue 2, August 2026, Pages 499-500
